As part of its continuing expansion, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce further key appointments within its Northern Ireland team. Dr Louise Ryan Murphy joins …
As part of its continuing expansion, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce further key appointments within its Northern Ireland team. Dr Louise Ryan Murphy joins …
Presenting the high-achieving NI companies hoping for Belfast Telegraph Business Awards 2022 success – BelfastTelegraph.co.uk The team at ProAxsis Limited is delighted to have been shortlisted in the Best …
ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, has successfully completed the Performance Evaluation study of the COVID-19 antibody test, initially created by AstraZeneca, with impressive results. The assay …
ProAxsis Limited, the Belfast-based diagnostics company, today announces an expansion of its activities in Asia, via a partnership with Kyberlife, a Singapore-based company offering a novel e-commerce platform. The …
ProAxsis Limited, the Belfast-based diagnostics company, today announces that in partnership with Dr Rich Williams, a Senior Lecturer in the School of Medicine, Dentistry and BioMedical Sciences at Queen’s …
Introduction As 2022 commences, I am pleased to provide an update on the progress made with regard to a number of the company’s key objectives announced during 2021. The …
As part of its ongoing expansion plans, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce the appointment of Alison Gillan as its new Management Accountant. Alison Gillan …
Dr Darragh McCafferty, ProAxsis’ Head of Assay Development, will be presenting new data on the company’s ongoing project to develop a quantitative version of its neutrophil elastase point-of-care test …
Our CEO, Dr David Ribeiro, will be attending the DxPx Conference, taking place face-to-face in Dusseldorf and in a virtual format, November 12th – 20th 2021. ProAxsis are actively …
ProAxsis is delighted to announce the approval of a key US patent for the underlying technology associated with its brand-new K-POSTN Assay, which the company intends to launch shortly. …
ProAxsis Ltd
Unit 1B, Concourse Building 3,
Catalyst Inc,
Queen’s Road, Titanic Quarter,
Belfast,
BT3 9DT,
Northern Ireland
tel +44 (0)28 9073 0444
email info@proaxsis.com